Nuclease-mediated DNA assembly
C Schoenherr, J McWhirter, C Momont… - US Patent …, 2019 - Google Patents
WO 2011154927 12/2011 WO 2013/142578 A1 9/2013 WO 2014089290 A1 6/2014 WO
2014093622 A2 6/2014 WO 2014143381 9/2014 WO 2015095804 6/2015 WO 2015200334 …
2014093622 A2 6/2014 WO 2014143381 9/2014 WO 2015095804 6/2015 WO 2015200334 …
Methods for scarless introduction of targeted modifications into targeting vectors
S Brydges, JF Rojas, GS Warshaw, CJ Siao - US Patent 11,111,504, 2021 - Google Patents
Methods for introducing a scarless targeted genetic modifi cation into a preexisting targeting
vector are provided. The methods can use combinations of bacterial homologous …
vector are provided. The methods can use combinations of bacterial homologous …
Nuclease-mediated DNA assembly
C Schoenherr, J McWhirter, C Momont… - US Patent …, 2020 - Google Patents
US10626402B2 - Nuclease-mediated DNA assembly - Google Patents US10626402B2 -
Nuclease-mediated DNA assembly - Google Patents Nuclease-mediated DNA assembly …
Nuclease-mediated DNA assembly - Google Patents Nuclease-mediated DNA assembly …
Methods for assembling nucleic acids
JE Gill, L Fu, DG Gibson - US Patent 12,018,316, 2024 - Google Patents
The invention provides methods of assembling a DNA molecule having a desired sequence.
The methods involve contacting a DNA ligase with a plurality of short oligonucleotides to be …
The methods involve contacting a DNA ligase with a plurality of short oligonucleotides to be …
Methods for scarless introduction of targeted modifications into targeting vectors
S Brydges, JF Rojas, GS Warshaw, CJ Siao - US Patent 11,499,164, 2022 - Google Patents
3568470 A1 3831941 A1 2496849 WO 2009/103027 A2 WO 2010/102257 A2 WO
2013/142578 A1 WO 2014/089290 A1 WO 2014/093622 A2 WO 2015/200334 A1 WO …
2013/142578 A1 WO 2014/089290 A1 WO 2014/093622 A2 WO 2015/200334 A1 WO …
Nuclease-mediated DNA assembly
C Schoenherr, J McWhirter, C Momont… - US Patent …, 2024 - Google Patents
Methods are provided herein for assembling at least two nucleic acids using a sequence
specific nuclease agent (eg, a gRNA-Cas complex) to create end sequences having …
specific nuclease agent (eg, a gRNA-Cas complex) to create end sequences having …